Christine Guillen active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ELSALYS BIOTECH | Director/Board Member | 2012-12-31 | - |
| Chief Executive Officer | 2012-12-31 | - | |
| Founder | 2012-12-31 | - |
Career history of Christine Guillen
Former positions of Christine Guillen
| Companies | Position | Start | End |
|---|---|---|---|
| TRANSGENE | Corporate Officer/Principal | 2007-10-31 | 2012-12-31 |
EUSA Pharma SAS
 EUSA Pharma SAS BiotechnologyHealth Technology EUSA Pharma SAS specializes in pharmaceutical research for rare diseases. The company was founded by Gilles Alberici on September 24, 1999 and is headquartered in Limonest, France. | Corporate Officer/Principal | 2005-04-30 | 2007-09-30 |
Statistics
International
| France | 4 |
Operational
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| TRANSGENE | Health Technology |
| Private companies | 2 |
|---|---|
ElsaLys Biotech SAS
 ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology ElsaLys Biotech SAS provides therapeutic monoclonal antibody player services. It involves in cellular events at the core of the pathological process: immune response, angiogenesis, survival, proliferation, adhesion and migration. The company also designs and develops a new generation of antibodies that target tumors and their immune microenvironment. ElsaLys Biotech was founded by Christine Guillen, Thierry Menguy, Vanessa Duong, and Martine Brandt in 2013 and is headquartered in Lyon, France. | Health Technology |
EUSA Pharma SAS
EUSA Pharma SAS BiotechnologyHealth Technology EUSA Pharma SAS specializes in pharmaceutical research for rare diseases. The company was founded by Gilles Alberici on September 24, 1999 and is headquartered in Limonest, France. | Health Technology |
- Stock Market
- Insiders
- Christine Guillen
- Experience
